|
 |
Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery
DJ Angiolillo, MS Firstenberg, MJ Price... - JAMA: The Journal of ..., 2012 - Am Med Assoc Abstract Context Thienopyridines are among the most widely prescribed medications, but their use can be complicated by the unanticipated need for surgery. Despite increased risk of thrombosis, guidelines recommend discontinuing thienopyridines 5 to 7 days prior to ...
Author Affiliations: Department of Cardiology, University of Florida, Jacksonville (Dr Angiolillo); Division of Cardiothoracic Surgery, Ohio State University Medical Center, Columbus (Dr Firstenberg); Division of Cardiovascular Diseases, Scripps Clinic and Scripps Translational Science Institute, La Jolla, California (Drs Price and Topol); Department of Cardiology, Northeast Georgia Heart Center, Gainesville (Dr Tummala); First Internal Clinic, Faculty Hospital Olomouc, Olomouc, Czech Republic (Dr Hutyra); Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina (Dr Welsby); Department of Cardiology, Henry Ford Hospital, Detroit, Michigan (Dr Voeltz); Department of Cardiology, Detar Hospital, Victoria, Texas (Dr Chandna); Deptartment of Surgery, University of Kentucky, Lexington (Dr Ramaiah); Deptartment of Cardiac Surgery, University Hospital, Hradec Kralove, Czech Republic (Dr Brtko); The Cardiac & Vascular Research Center of Northern Michigan, Northern Michigan Regional Hospital, Petoskey (Dr Cannon); South East Texas Cardiovascular Surgery Associates, Humble (Dr Dyke); The Medicines Company, Parsippany, New Jersey (Drs Liu and Prats); Groupe Hospitalier Pitié-Salpêtrière, Université Paris 6, INSERM CMR 937, Paris, France. (Dr Montalescot); Sarah Cannon Research Institute and Hospital Corporation of America, Nashville, Tennessee, (Dr Manoukian); BRIDGE Investigators: Maintenance of platelet inhibition with cangrelor after discontinuation of thienopyridines in patients undergoing surgery (BRIDGE).
More Details:
Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery |
|
|
